![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_7de5848be93196a6906eba944a298431.svg) | Sunitinib | IC50 | 83.1 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_7de5848be93196a6906eba944a298431.svg) | Sunitinib | Ki | 8.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_8a69b3902a36c5bcb114db8f49f8eabe.svg) | Semaxanib | IC50 | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_611c45cf8ec38c9b079948751bd21341.svg) | 3-(4-(Dimethylamino)benzylidene)-1,3-dihydro-2H-indol-2-one | IC50 | 3750.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_e2f99194617c96946324b426e112d809.svg) | Erlotinib | IC50 | 12200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 0.6 [1], 0.76 [2], 4.3 [3], 4.7 [4], 204.7 [5] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_c8494007663098abb5d227cb27cc738b.svg) | Sorafenib | IC50 | 10.0 [1], 18.4 [2], 37.0 [3], 57.0 [4] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_8edb893ba88c5700603edef201da4265.svg) | Nintedanib | IC50 | 1.8 [1], 2.0 [2], 3.5 [3], 3.7 [4], 65.0 [5] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_37acee0cd10541aa0b3bd57948b54806.svg) | Orantinib | IC50 | 50.0 [1], 60.0 [2], 100.0 [3], 16500.0 [4] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_b2d54f313fd6fae3559ad99a1d264705.svg) | Imatinib | IC50 | 72.0 [1], 240.0 [2], 386.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_892aa79f14eda2e212e853914442f44b.svg) | 3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone | IC50 | 510.0 [1], 28400.0 [2], 60900.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_e98e38f8f3edf8be20fec1223eba919f.svg) | 6,7-Dimethyl-2-phenylquinoxaline | IC50 | 6200.0 [1], 6500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_b2e0374192c14780687bb9ed1d5a397b.svg) | PDGF Receptor Tyrosine Kinase Inhibitor III | IC50 | 80.0 [1], 130.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_aad5240e9c96fb698e391fe66cef5fea.svg) | 4-N-(3-Bromophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_4e53db16979c93e82f7fbd654a494204.svg) | 4-N-(3-Bromophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 8900.0 [1], 8920.0 [2], 300000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_c7ea91415258cf701a653bfc92e395ff.svg) | (5-Hydroxy-1H-indol-2-yl)-(1H-indol-2-yl)methanone | IC50 | 90.0 [1], 200.0 [2], 600.0 [3], 3200.0 [4] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_fa164f67dd00f6d2e9f05348b548a4dc.svg) | 4-(6,7-Dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)-1-piperazinecarboxamide | IC50 | 240.0 [1], 700.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_9dabcb9dd97dc98e9c2238fea0fb3696.svg) | Glycine, N,N-dimethyl-, 2-(1H-indol-2-ylcarbonyl)-1H-indol-5-yl ester | IC50 | 100.0 [1], 1300.0 [2], 3500.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 1000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_9d111ca31c6b5557bbe95cc7cad92c76.svg) | Vatalanib | IC50 | 490.0 [1], 600.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_4ee8632c180d42f14a1148faf37622c7.svg) | Tandutinib | IC50 | 26.0 [1], 36.0 [2], 200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_4e38800d1c310079b3b3e65c5db78d0d.svg) | Linifanib | IC50 | 60.0 [1], 66.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_8030213d9f30efd3da30350a03e56f0d.svg) | PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 3.0 [1], 4.2 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_34d56ed9b81c1d4adb6e33de1f3909ba.svg) | 5-[(Z)-(5-Chloro-2-oxo-1H-indol-3-ylidene)methyl]-N-[2-(diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | IC50 | 3.0 [1], 3000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_6365365977462e08c2ff13fed8625161.svg) | 7-(2,6-Dichlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_6365365977462e08c2ff13fed8625161.svg) | 7-(2,6-Dichlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | Ki | 2090.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ac9e30b723e2c9bf1debc2a45966acbb.svg) | 3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione | IC50 | 680.0 [1], 1867.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_e610c2d08ff0a822b4e8c7ed2a80b2b9.svg) | N4-(3-Bromophenyl)-6-(naphthalen-1-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 50000.0 [1], 300000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_a1c584a0569c487c0d6e91dd89b49d93.svg) | 2-Benzyl-N4-(3-bromophenyl)-1H-indole-4,6-diamine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_a96579df53e7541e76ee32b51942a8f5.svg) | 4-[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 10.0 [1], 40.0 [2], 525.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_d314a05f0f8d40841f85d577da4a24e4.svg) | N-(4-Cyanophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide | IC50 | 450.0 [1], 850.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_be130926288e95a2e738065fb0b2790a.svg) | Acetic acid, methoxy-, 2-(1H-indol-2-ylcarbonyl)-1H-indol-5-yl ester | IC50 | 20.0 [1], 100.0 [2], 4200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_3e8f8ba205c9802c05139696f3b029b2.svg) | 4-[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide | IC50 | 200.0 [1], 216.0 [2], 420.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_d6f344a344dcbcb36b684e432cc5389e.svg) | 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[(6-methylpyridin-3-yl)methyl]piperazine-1-carbothioamide | IC50 | 90.0 [1], 140.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ff09a65fc0f981787bdc265550c19895.svg) | N-(4-Cyanophenyl)-4-[6-methoxy-7-[3-(2-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide | IC50 | 4.0 [1], 29.0 [2], 150.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ce88ada74ae414ee198727142d80be24.svg) | 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[(5-methylpyrazin-2-yl)methyl]piperazine-1-carbothioamide | IC50 | 50.0 [1], 140.0 [2], 1350.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_5a743c7ac6538dde9b16b2ce71a55933.svg) | N-[(6-Chloropyridin-3-yl)methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide | IC50 | 50.0 [1], 80.0 [2], 1010.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_5173b89c258c1191d31f1ab626f934d2.svg) | N-(4-Isopropoxyphenyl)-4-(6-methoxy-7-(3-morpholinopropoxy)quinazolin-4-yl)piperazine-1-carboxamide | IC50 | 20.0 [1], 60.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_7511702f0b657b9b0d4c15e667313ade.svg) | 4-[6-Methoxy-7-[3-(4-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide | IC50 | 4.0 [1], 39.0 [2], 51.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_c870d170b2bed90153d3e8517c8561f9.svg) | N-(4-Cyanophenyl)-4-[6-methoxy-7-[3-(4-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide | IC50 | 4.0 [1], 22.0 [2], 73.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_f2b8e9fc1f5724e35986749a342ef3ea.svg) | 4-[6-Methoxy-7-[3-(2-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide | IC50 | 4.0 [1], 35.0 [2], 74.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_afae7a3211a196abd8317e30a403861d.svg) | 4-[6-Methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]-N-pyridin-4-ylpiperazine-1-carbothioamide | IC50 | 240.0 [1], 400.0 [2], 980.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_06c1e9d3b441b018562486c7abdc6343.svg) | 4-[6-Methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]piperazine-1-carbothioamide | IC50 | 90.0 [1], 150.0 [2], 1030.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_c238a5faa3e5d1be5c7fca23b5cebaf3.svg) | 4-[3-Cyano-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]piperazine-1-carbothioamide | IC50 | 3.0 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_52a64e461efa93508e669826e5fbc94b.svg) | N-[[2-Chloro-6-(trifluoromethyl)pyridin-3-yl]methyl]-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide | IC50 | 100.0 [1], 1130.0 [2], 1400.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_1abd6d59b3415986cf76b48c52bc8317.svg) | N-(6-Chloropyridin-3-yl)-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide | IC50 | 360.0 [1], 510.0 [2], 890.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_5305a2fada9bd46600c1402fbc888305.svg) | 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(6-phenylpyridin-3-yl)piperazine-1-carbothioamide | IC50 | 100.0 [1], 270.0 [2], 360.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_43dbe548142df8ad76b85a7a9e9b188a.svg) | 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[(5-methylfuran-2-yl)methyl]piperazine-1-carbothioamide | IC50 | 80.0 [1], 90.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_5f4fab36889e1d8d2107fab1b0976242.svg) | 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-pyridin-4-ylpiperazine-1-carbothioamide | IC50 | 60.0 [1], 220.0 [2], 580.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_cce27475bd621007be418f7d629eb9e1.svg) | N-(Furan-2-ylmethyl)-4-[6-methoxy-7-(2-pyrrolidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide | IC50 | 160.0 [1], 290.0 [2], 310.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_b30dd38cee2038f4c08f58b185ab51c0.svg) | Bis(1H-2-indolyl)methanone deriv. 50 | IC50 | 70.0 [1], 300.0 [2], 4900.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_af55288d22bd84f4fbc0cc6c178047b9.svg) | 4-[6-Methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]-N-[(5-methylpyrazin-2-yl)methyl]piperazine-1-carbothioamide | IC50 | 50.0 [1], 60.0 [2], 250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_19a4dac762f2026844078c235ced8ec7.svg) | 4-[6-Methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide | IC50 | 170.0 [1], 250.0 [2], 1250.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_35e541cd869d0e6c986935a7e35c77c0.svg) | N-(1,3-Benzodioxol-5-ylmethyl)-4-[6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]piperazine-1-carbothioamide | IC50 | 20.0 [1], 40.0 [2], 120.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_cc1cdcf33b1e1eeb5b4cc5fac96f1abc.svg) | 4-[6-Methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-yl]-N-(4-pyridin-2-ylphenyl)piperazine-1-carbothioamide | IC50 | 70.0 [1], 150.0 [2], 180.0 [3] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_755000a88f2651809d912de0f446bcfe.svg) | Lapatinib | IC50 | 8500.0 [1], 200000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_f59214b920b0faf58103b7de887f46c7.svg) | Nilotinib | IC50 | 60.11 [1], 71.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_1c0dbc70a65a3eccf3e39ecce75f7f37.svg) | Pazopanib | IC50 | 83.0 [1], 84.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_7c1f47f3c7bae38fb065c983ece631c1.svg) | Vandetanib | IC50 | 477.0 [1], 1100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_47d151d561f848592c41ab2966c047a4.svg) | Dovitinib | IC50 | 1.0 [1], 5.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_173905a1d8206fe6271a8ee9486c99d9.svg) | Foretinib | IC50 | 9.6 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_529828b056b2f30ac4801342ca43d9f7.svg) | (3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-one | IC50 | 10000.0 [1], 18000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_b63a2565bd4d512206a1c9679cacee61.svg) | 3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide | IC50 | 1860.0 [1], 2636.67 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ae13ba0ef97df3d11c086aa578368679.svg) | 4-Chloro-3-(5-methyl-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)benzo[e][1,2,4]triazin-7-yl)phenol | IC50 | 1.1 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_3d027434bed540e43919919e9f91203b.svg) | VEGF Receptor 2 Kinase Inhibitor I | IC50 | 4000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_7ba2c79d04a961439347046220210c11.svg) | 2-(4-((6,7-Dimethoxyquinazolin-4-yl)oxy)phenyl)-N-(1-isopropyl-1H-pyrazol-4-yl)acetamide | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_9991016043a659640f103b51434e54d1.svg) | 7-(2,6-Dimethylphenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | IC50 | 5.9 [1], 6.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_5eda0bfba1b6839b8a41198b49d55f46.svg) | (Z)-3-(2,4-Dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid | IC50 | 10.0 [1], 110.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_017ea60e9b689094fe878e36635d2d23.svg) | N-(4-Chlorophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide | IC50 | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_c7c31ad92e1b0b77d0138e3a513f200e.svg) | N-Benzyl-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamide | IC50 | 90.0 [1], 550.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_2bced59f0544a1d307819661165e96b1.svg) | 6-(2-Phenylethyl)-4-N-[3-(trifluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 500000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_56be305ce0bc0e4819b6a91347a654e8.svg) | 2-(2-Chlorobenzyl)-N4-(3-bromophenyl)-1H-indole-4,6-diamine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_34460eced46bc8ebc7b3f8f893071678.svg) | N-(4-Methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine | IC50 | 22.8 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_a3bb3a5f0dd6cc174d624dfab74909ff.svg) | 2-[4-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]-N-(1-propan-2-ylpyrazol-4-yl)acetamide | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_fd951065be8c84c1b332e18593d47262.svg) | N-(1,3-Benzodioxol-5-ylmethyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamide | IC50 | 90.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_d87e6323a66e08385e4942749cbe0168.svg) | 4-(7-Ethoxy-6-methoxyquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_1eea5d53cfa9292d5b7c2a6489c9d3b2.svg) | 4-N-(3-Bromo-4-fluorophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 500000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ff9c97ae965f3c38b1a326d77574c930.svg) | N-(4-Bromophenyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carboxamide | IC50 | 270.0 [1], 530.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_95493f8d18603aa8ebb85025d281548b.svg) | 4-(6,7-Dimethoxyquinazolin-4-yl)-N-(4-propan-2-ylphenyl)piperazine-1-carboxamide | IC50 | 20.0 [1], 80.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_2c220a9b23bebecc28149e83d5a6ca04.svg) | N-Benzyl-4-(7-ethoxy-6-methoxyquinazolin-4-yl)piperazine-1-carbothioamide | IC50 | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_b0c352eccc86687d7f6d5e8d89cf6c62.svg) | 4-(6-Ethoxy-7-methoxyquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_bf949f914aae7762b904d219cef4d9e4.svg) | 4-(6,7-Dimethoxy-2-methylquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_7db2fc6e2d0ee9f858b9d64290e32d4c.svg) | 4-[6-Amino-7-(ethylamino)quinazolin-4-yl]-N-benzylpiperazine-1-carbothioamide | IC50 | 1440.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_514442ecc2405036703f00ef4e8b8edd.svg) | 4-(2-Chloro-6,7-dimethoxyquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_4d413ef0506722bae4423fa136d3095d.svg) | N-Benzyl-4-quinazolin-4-ylpiperazine-1-carbothioamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_668c42dea08aad94a8a2e416b172aa8f.svg) | 4-[7-(Ethylamino)-6-nitroquinazolin-4-yl]-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_431093f92e81193dd5bf14e0f25e5f8a.svg) | N-(4-Phenoxyphenyl)-4-(6,7,8-trimethoxyquinazolin-4-yl)piperazine-1-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_e0ec6b65a5420cd0c49d6eefe89228ee.svg) | N-Benzyl-4-(6-ethoxy-7-methoxyquinazolin-4-yl)piperazine-1-carbothioamide | IC50 | 620.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_bd189879582971c8b3af16823f1d2978.svg) | N-Benzyl-4-[7-(ethylamino)-6-nitroquinazolin-4-yl]piperazine-1-carbothioamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_be4b56472aa2053da9f2863c81065808.svg) | 4-(7,8-Dimethoxyquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_172dcae4e2de72109950f50b16c3b395.svg) | N-(4-Phenoxyphenyl)-4-quinazolin-4-ylpiperazine-1-carboxamide | IC50 | 380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_3f228b1d3c008bf48358db4160ec9ed2.svg) | 4-(6,7-Dimethoxy-2-morpholin-4-ylquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_d691451f0ecf2e29c1eda04657f17857.svg) | (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-phenyl amine | IC50 | 9.0 [1], 23.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_addcdf049b57b51ffeff10dd34c1f8df.svg) | (5-Methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine | IC50 | 54.0 [1], 487.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_e3c00a5750c4db95e24532fbc0ceb6e5.svg) | 4-Chloro-3-(5-methyl-3-(4-(piperidin-4-ylsulfonyl)phenylamino)benzo[e][1,2,4]triazin-7-yl)phenol | IC50 | 2.8 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ca486d82e7b17cedd59905fcba252f83.svg) | 4-[[7-(2-Chloro-5-hydroxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino]-N-(2-pyrrolidin-1-ylethyl)benzenesulfonamide | IC50 | 1.7 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_67cb07e453438c1319b619760a1e9995.svg) | (7-Methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine | IC50 | 9.0 [1], 18.0 [2] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_e1fb5cf02d306943f82efb7ba638e82b.svg) | 4-(6,8-Dimethoxyquinazolin-4-yl)-N-(4-phenoxyphenyl)piperazine-1-carboxamide | IC50 | 10900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_72d49d50cb039f20084db43546076f56.svg) | 4-N-[4-Fluoro-3-(trifluoromethyl)phenyl]-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 90000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/platelet-derived-growth-factor-receptor-beta_ea05fd4048f493678664297a5b3ae7b6.svg) | 4-N-(3-Bromophenyl)-6-[(2,4-dichlorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 17000.0 [1] |